Track the Goldline Pharmaceutical share price and the full insider trade history of the company, a publicly traded company based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Market capitalisation: €393.6m. The latest transaction was reported on 1 September 2026 (Acquisition). Among the most active insiders: Amol Laxmikant Mujumdar. All data is free.
6
Insider Decl.
n/a
Thresholds
€24,065
6 ops.
Buy Volume
n/a
n/a
Sell Volume
38Σ signal
Buys €24,065n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,272 of 29,063 companies
72.7
score / 100
Value
72
Quality
74
FCF yld5.4%
Earn yld7.2%
EV/EBITDA8.5x
ROE34%
Gross mgn62%
Net mgn10%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.